Generic Nasonex Nasal Spray Approved — Physician’s First Watch
Generic Nasonex Nasal Spray Approved
By Kristin J. Kelley
Edited by David G. Fairchild, MD, MPH
The first generic version of mometasone furoate monohydrate (Nasonex nasal spray) has been approved by the FDA, according to the drug's manufacturer.
The nasal spray is used to treat allergy symptoms (seasonal and perennial allergic rhinitis) in adults and children aged 2 years and older and nasal polyps in adults. It is also approved to prevent seasonal allergies in patients 12 years and older.
Patients with vision problems, tuberculosis, or recent nasal injury, sores, or surgery, should disclose these conditions to a healthcare provider before using the nasal spray. See the prescribing label for further cautions.